G2R-14184-16839
2 vaccinations
3 coded responses
21 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 120 / NY
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Registered in v-safe
-
2021-03-02
Dose 1 — Pfizer-BioNTech
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
-
2021-03-08
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
- 2021-03-16
-
2021-03-23
Dose 2 — Pfizer-BioNTech
- 2021-03-23
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-29
- 2021-04-01
- 2021-04-06
- 2021-04-22
- 2021-04-27
-
2021-05-04
Survey response — day 42, dose 2MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: C section recoveryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-27
- 2021-06-22
-
2021-09-21
Survey response — 6 months, dose 2MedDRA: Dizziness, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Dizziness and light headedness · Healthcare visit (other): Doctor's Office VisitMedDRA releases: 2024-11 · check-in free text available
-
2021-09-21
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-23 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Bruise at injection site
Release 8 — day 42, dose 2
Symptoms: C section recovery
Release 9 — 6 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release